PsychonautWiki Archive

3C-P: Difference between revisions

>Bindingaffinity
create a basic 3C-P page based on 3C-E
 
>David Hedlund
{{Experience reports|erowid_experience_substance_label=3C-P}}
 
(14 intermediate revisions by 8 users not shown)
Line 1: Line 1:
{{SummarySheet}}
{{SubstanceBox/3C-P}}
{{approval}}
{{approval}}


'''3,5-Dimethoxy-4-propoxyamphetamine''' (commonly known as '''3C-P''' or '''3C-Proscaline''') is a synthetic [[psychoactive class::psychedelic]] compound of the [[chemical class::Substituted amphetamines|amphetamine]] chemical class. Although its name suggests it may be related to the [[2C-x]] family, this is not the case since it is the 3-Carbon analog of [[proscaline]]
'''3,5-Dimethoxy-4-propoxyamphetamine''' (also known as '''3C-P''' or '''3C-Proscaline''') is a lesser-known [[psychoactive class::psychedelic]] substance of the [[chemical class::Substituted amphetamines|amphetamine]] class. Although its name suggests it may be related to the [[2C-x]] family, this is not the case since it is the 3-Carbon analog of [[proscaline]].


It was presumably first synthesized by [[Alexander Shulgin]] and published in his book [[PiHKAL]] in 1991.
The original synthesis date of 3C-P is unknown. Its theoretical synthesis is briefly mentioned in [[Alexander Shulgin|Alexander Shulgin's]] book [[PiHKAL]], in which it is speculated to have psychedelic properties and a presumed dosage range of 20 to 40 milligrams.<ref>https://erowid.org/library/books_online/pihkal/pihkal140.shtml</ref> It is typically sold on the online [[research chemical]] market.


Today, 3C-P is used for [[recreational drug use|recreational]] and research purposes, and exclusively distributed as a gray area [[research chemical]] by online vendors. Very little is known about its effects.  
Very little data exists about the pharmacological properties, metabolism, and toxicity of 3C-P, and it has only a brief history of human usage. It is highly advised to use [[harm reduction practices]] if using this substance.


==Chemistry==
==Chemistry==
Line 19: Line 22:


3C-P's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive.
3C-P's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive.
According to the structure-activity-relationship between mescaline analogues, 3C-P has been identified as being more potent than [[mescaline]] and [[TMA-2]]. It has similar potency in animal studies to 3C-E, and the authors of one study on potency of mescaline analogues in rats predict that it may have similar effects and dosage to 3C-E.<ref>Halberstadt, AL; Chatha, M; Chapman, SJ; Brandt, SD. [https://bitnest.netfirms.com/external/10.1177/0269881119826610 Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.] ''J. Psychopharmacol.'', 21 Feb 2019,  ''0269881119826610''. 901 kB. <nowiki>https://doi.org/10.1177/0269881119826610</nowiki></ref>


==Subjective effects==
==Subjective effects==
{{Preamble/SubjectiveEffects}}
{{Preamble/SubjectiveEffects}}
{{effects/base
{{effects/base


|{{effects/physical|
|{{effects/physical|


*'''[[Effect::Stimulation]]''' - In terms of its effects on the physical energy levels of the user, 3C-E is usually considered to be moderately to extremely stimulating. In comparison, other more commonly used psychedelics such as [[psilocin]] are sedating and relaxed.
*'''[[Effect::Stimulation]]''' - In terms of its effects on the physical energy levels of the user, 3C-P is usually considered to be moderately to extremely stimulating. In comparison, other more commonly used psychedelics such as [[psilocin]] are sedating and relaxed.
*'''[[Effect::Spontaneous physical sensations]]'''
*'''[[Effect::Spontaneous physical sensations]]'''
**'''[[Effect::Physical euphoria]]'''
**'''[[Effect::Physical euphoria]]'''
Line 70: Line 76:


====[[Effect::Geometry]]====
====[[Effect::Geometry]]====
The visual geometry encountered on 3C-P can be described as similar in appearance to that of [[LSD]], [[2C-B]] and [[2C-I]].
The geometry can be comprehensively described as synthetic in style, algorithmic in appearance, intricate in complexity, structured in organization, fast in speed, smooth in motion, small in appearance, multicolored in scheme, glossy in color, and sharp and angular in its corners.
*'''[[Geometry#Level_8A_vs._level_8B|Level 8B]]''' - While the geometry produced by 3C-P has yet to be fully characterized, the geometry gives off certain attributes which are significantly more likely to result in states of [[level 8A]] visual geometry over [[level 8B]] at higher doses.


====Hallucinatory states====
====Hallucinatory states====
Line 80: Line 91:
|{{effects/cognitive|
|{{effects/cognitive|


The total sum of these cognitive components regardless of the setting generally includes:
The cognitive effects of 3C-P are described as primarily stimulating than psychedelic and more confusing than [[3C-E]], especially at higher dosages. The total sum of these cognitive components regardless of the setting generally includes:


*'''[[Effect::Conceptual thinking]]'''
*'''[[Effect::Conceptual thinking]]'''
Line 123: Line 134:
}}
}}
===Experience reports===
===Experience reports===
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here:
{{Experience reports|erowid_experience_substance_label=3C-P}}
 
*[https://erowid.org/experiences/subs/exp_3CP.shtml Erowid Experience Vaults: 3C-P]


==Toxicity and harm potential==
==Toxicity and harm potential==
Line 136: Line 145:
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance.
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance.


===Tolerance and addiction potential===
===Dependence and abuse potential===
3C-P is [[Addiction potential::not habit-forming]], and the desire to use it can actually decrease with use. It is most often self-regulating.  
3C-P is [[Addiction potential::not habit-forming]], and the desire to use it can actually decrease with use. It is most often self-regulating.  


Line 150: Line 159:
*'''United Kingdom''': It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>
*'''United Kingdom''': It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>
*'''United States''': 3C-P is technically not scheduled in the United States, but could be considered an analog of [[mescaline]] and may, therefore, be considered a Schedule I drug under the Federal Analogue Act.
*'''United States''': 3C-P is technically not scheduled in the United States, but could be considered an analog of [[mescaline]] and may, therefore, be considered a Schedule I drug under the Federal Analogue Act.
*'''Japan''': 3C-P is a controlled substance in Japan effective February 28th, 2018.<ref>[https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/oshirase/20180228-1.html 指定薬物を指定する省令が公布されました] (in Japanese). 厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]. Retrieved May 2, 2022.</ref>


==See also==
==See also==
Retrieved from "http://psy.st/wiki/3C-P"